February 9, 2026 – As part of his official tour of Northern Greece, the Ambassador of Indonesia, H.E. Dr. Bebeb A.K. Nugraha Djundjunan, visited RGCC’s laboratories in the Industrial Zone of Florina on February 9, 2026. The visit followed an invitation from RGCC’s leadership and came after his recent meeting with RGCC Founder and Director, Dr. Ioannis Papasotiriou, in Athens on January 10, 2026.
Accompanied by representatives of RGCC subsidiaries in Asia, the Ambassador received a guided tour of the state-of-the-art facilities. He was introduced to the company’s advanced technologies, innovative research activities, and the high-quality standards that underpin RGCC’s operations in Greece and internationally.
During the luncheon that followed, Dr. Papasotiriou presented recent developments in cancer management through genetic research, an area in which RGCC maintains a strong global presence. Discussions also addressed the issue of unequal patient access to approved Advanced Therapy Medicinal Products (ATMPs), highlighting challenges related to regulatory delays observed in certain EU countries.
The visit concluded with a mutual expression of intent to strengthen collaboration through the exchange of expertise and resources, reflecting a shared commitment to advancing scientific progress and improving patient outcomes.
About RGCC International:
RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou who believes that the key to effectively treating cancer lies in personalized medicine. Today, RGCC is a leading innovator in the field of oncology diagnostics. Using world-leading technology, equipment, and innovative techniques, our team of scientists has developed a range of liquid biopsies that help physicians track cancer progression and tailor treatment plans based on individual patient profiles.
For more info visit: rgcc-international.com